Global Jet Lag Therapy Market Analysis and Forecast 2017-2023: Focus on Product, End User and Competitive Landscape - Research and Markets

DUBLIN, Apr. 25, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Jet Lag Therapy Market - Analysis and Forecast (2017-2023) (Focus on Product, End User and Competitive Landscape)" report to their offering.

The global jet lag therapy market is expected to reach $732.4 million in 2023

Global Jet Lag Therapy products are primarily used to cure jet lag symptoms, which includes insomnia, sleepiness, daytime fatigue, lack of concentration, constipation, diarrhea, dehydration, and nausea among others. Chronic illness of jet lag, if left undetected, further leads to the occurrence of severe depression and certain types of cancer, which results in jet lag and related diseases being a predominant challenge to global healthcare systems since they have a complicated and expensive treatment procedure. The jet lag therapy market comprises of an array of competent technologies such as, wearable light therapy devices, portable light therapy products, different types of drugs and herbal products.

In the past two decades, numerous changes have occurred in the science of jet lag management. Jet lag symptoms lead to a number of substantial health hazards to athletes, business executives and seasonal travelers, affecting millions of people and cost more than a $1 billion annually. It has been observed that jet lag have peculiar effects on the quality of lives of the travelers or those affected with this condition.

There has been profound advancement in the development of new and modern technologies that possess symptom prevention properties with minimum side effects, as compared to traditional products such melatonin and prescription drugs. At present, owing to the rigorous research and development activities along with positive outcomes of clinical trials, market players operating in the jet lag treatment market have been successful in developing advanced and cost effective jet lag management products such as light box, wearable mask, glasses, and ear buds among others.

The major factors contributing to the growth of jet lag therapy market are: growing elderly population, and rising incidence and prevalence rate of circadian rhythm related problems such as jet lag, winter blues, and sleep disorders. Moreover, high rate of awareness about advanced light therapy and treatment with minimum side-effects would drive the growth of medical devices products such as wearable light therapy devices.

The global incidence rate of jet-lag is still unknown, but it impacts a high percentage of approximately 30 million plus jet travelers who leave the U.S. yearly for destinations that cross five or more time zones. Globally, jet lag affects more than 100 million people annually. Jet lag is not just a problem faced by tourists; it can also temporarily impair the judgment of business people and executives, compromise the performance of athletes, and poses a threat to public safety as it affects diplomats and the military. As of 2015, it was estimated that jet lag affects more than 11 million U.S. residents who flew overseas, over 13 million European travelers and 7 million Asian travelers. This include military or government flights. Those traveling for business and conventions took an average of 4.5 trips in a year.

Key Topics Covered:

Executive Summary   

1 Report Scope and Methodology 

2 Market Overview   
2.1 Introduction  
2.2 Travel Direction and Time Zone  
2.3 Jet Lag Treatment  

3 Target Population   
3.1 U.S. Circadian Rhythm Disorder Statistics  
3.2 Global Air Passenger Statistics  
3.3 Target Population Analysis  

4 Market Dynamics   
4.1 Overview  
4.2 Market Drivers  
4.3 Market Challenges  
4.4 Market Opportunities  

5 Competitive Landscape   
5.1 Key Developments & Strategies   
5.2 Market Share Analysis  
5.3 Comprehensive Competitive Index (CCI) 
5.4 Growth Share Matrix 

6 Industry Insights   
6.1 Patent Landscape  
6.2 Legal Developments  

7 Global Jet Lag Therapy market, By Products   
7.1 Overview   
7.2 Key Insights  
7.3 Prescription Drugs  
7.3.1 Branded Prescription Drugs 
7.3.1.1 Provigil/Nuvigil 
7.3.1.2 Ambien
7.3.1.3 Lunesta
7.3.1.4 Sonata
7.3.2 Other Drugs 
7.4 Melatonin  
7.5 Herbal and Natural Products  
7.6 Medical Devices  
7.6.1 Light Box 
7.6.2 Wearable Devices  
7.6.2.1 Re-Timer
7.6.2.2 Propeaq Glasses 
7.6.2.3 AYO
7.6.2.4 Neuroon
7.6.2.5 Luminette
7.6.2.1 HumanCharger 
7.6.3 Wearable Devices Market Revenue 
7.6.4 Pipeline Wearable Devices 

8 Global Jet Lag Therapy market, By End-User   
8.1 Overview  
8.2 Business Travelers  
8.3 Cabin Crew  
8.4 Athletes  
8.5 Seasonal Travelers  

9 Global Jet Lag Therapy market, By Geography   

10 Company Profiles  

• Ayo (Novalogy) 
• Inteliclinic 
• Litebook Co. Ltd. 
• Lucimed 
• Lumie 
• Nature Bright 
• Northern Light Technologies 
• Propeaq 
• Re-Timer 
• Royal Philips 
• Valkee 
• Verilux, Inc.   
• Vielight Inc.

For more information about this report visit http://www.researchandmarkets.com/research/bx9zwq/global_jet_lag

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets